🇺🇸 FDA
Patent

US 11111494

Compositions for modulating Ataxin 2 expression

granted A61PA61P21/00A61P25/00

Quick answer

US patent 11111494 (Compositions for modulating Ataxin 2 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P21/00, A61P25/00, A61P25/16, A61P25/28